Study of outcomes after surgery for severe diabetic eye disease
Part of Eyes & vision clinical trials.
This study looks at how people with severe nonproliferative diabetic retinopathy do after they have vitrectomy (a type of eye surgery). The goal is to better predict prognosis and possibly improve care planning after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and can sign informed consent
- You have severe diabetic retinopathy, confirmed as “severe” by eye exam findings
- Your vision test score is in the study range (roughly 20/400 to 20/32)
- You should be able to cooperate with eye tests after surgery (including corneal clarity, good pupil dilation, and OCT scans)
- You have not had eye procedures like laser or non-cataract eye surgery recently, and no additional eye surgery is planned within 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
This trial compares a minimally invasive eye procedure (vitrectomy with peeling) versus anti-VEGF injections to treat new diabetic macular edema in people who have not had treatment yet. It looks at which option improves vision and eye swelling for people with diabetes.
This trial tests whether giving bevacizumab (a medicine that slows abnormal blood vessel growth) right after vitrectomy (a surgery to remove blood or scar tissue from the eye) can help people with advanced diabetic eye disease. The goal is to improve vision and reduce the need for more treatments.
This trial tests a different pattern of laser treatment for people with diabetic eye disease (proliferative diabetic retinopathy) that has started growing abnormal blood vessels. The goal is to see if this pattern works well or better than the standard approach.
This study looks at how well surgery works for people with a specific type of detached retina (rhegmatogenous retinal detachment). It may help improve how doctors choose and manage treatment, based on what outcomes happen after repair.
Hear when a new Non Proliferative Diabetic Retinopathy(NPDR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.